期刊文献+

米非司酮治疗子宫腺肌病的临床效果研究

下载PDF
导出
摘要 子宫腺肌病是指子宫内膜侵入子宫肌层而引起的病变。以往多采用消炎痛及孕激素治疗子宫腺肌瘤,但效果不理想,为寻求一种免于切除子宫且更有效的治疗方法,最大限度的满足患者的愿望,作者自2012年开始将米非司酮用于治疗子宫腺肌病,效果明显,现将结果报道如下。
作者 耿丽萍
出处 《实用妇科内分泌电子杂志》 2016年第19期31-31,33,共2页 Electronic Journal of Practical Gynecological Endocrinology
  • 相关文献

参考文献4

二级参考文献24

  • 1廖爱华.米非司酮的作用机理及临床应用[J].实用妇产科杂志,1994,10(1):15-16. 被引量:532
  • 2杨幼林,郑淑蓉,李克敏,张炳兰.两种不同剂量米非司酮治疗子宫肌瘤的疗效观察[J].中华妇产科杂志,1996,31(10):624-626. 被引量:217
  • 3[5]Brandon DD,Bethea CL,Strawn EY,et al.Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas.Am J Obstet Gyecol,1993,169(1):78
  • 4[6]Cameron ST,Critchley HOD,Thong KJ,et al.Effects of daily low dose mifepristone on endometrial maturation and proliferation.Hum Reprod,1996,11(11):2518
  • 5[7]Reinsch RC,Murphy AA,Morale AJ,et al.The effects of RU486 and leuprolide acete on uterine artery blood flow in the fibroid uterus: a prospective randomized study.Am J Obstet Gynecol,1994,170(9):1623
  • 6[8]Dixon D,He H,Haseman JK.Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium.Environmental Health Perspectives,2000,108(Suppl 5):795
  • 7[1]Brogden RN,Goa KL,Faulds D.Mifepristone-a review of its pharmacodynamic and pharmacokinetic properties,and therapeutic potential.Drugs,1993,45(3):384
  • 8[2]Murphy AA,Kettel LM,Morales AJ,et al.Regression of uterine leiomyoma in response to the antiprogesterone RU486.J Clin Endocrinol Metab,1993,76(4):513
  • 9[4]Kawaguchi D,Fujii S,Konishi I,et al.Ultrastructural study of cultured smooth muscle cells from uterine leiomyoma and myometrium under the influence of sex steroids.Gynecol Oncol,1985,21(1):32
  • 10Groenendyk J, Michalak M. Endoplasmic reticulum quality control and apoptosis [J]. Aeta Biochina Pol, 2005, 52(2) : 381- 395.

共引文献167

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部